Skip to content

Price / book at other companies

Eli Lilly logo
Eli LillyLLY
26.3×-20.7×
Johnson & Johnson logo
Johnson & JohnsonJNJ
7.3×+2.1×
Amgen logo
AmgenAMGN
20.6×-6.3×
AbbVie logo
AbbVieABBV
261×+221×
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
3.2×+2.0×
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
+4.3×

Other financials

Income statement

See full
Revenue-
Operating income-$15.5M-8.0%
Net income-$14.8M-7.8%
EPS (diluted)-$0.13+51.9%

Balance sheet

See full
Cash & equivalents$90.4M+48.5%
Total debt$2.9M-9.5%
Total equity$95.8M+41.8%
Total assets$102.1M+32.3%

Cash flow

See full
Operating cash flow-$13.4M-11.6%
CapEx$63.0K
Free cash flow-$13.5M-12.1%

Valuation

See full
Market cap$564.45M+1,131%
Enterprise value$476.92M-4,119%
P/S564.5×+554×

Profitability

See full
Operating margin-5,266.4%-9,520pp
Net margin-4,987.4%-8,966pp
FCF margin-4,140.8%-7,144pp

Returns & leverage

See full
Return on equity-61%-8.0pp
Debt / equity0.0×
Current ratio22.1×+13.0×

Where this comes from

Calculated from Shattuck Labs, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Shattuck Labs, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Shattuck Labs, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Shattuck Labs, Inc.'s price / book?
Shattuck Labs, Inc. (STTK) reported price / book of 4.8× in Q1 2026.
How has Shattuck Labs, Inc.'s price / book changed year-over-year?
Shattuck Labs, Inc.'s price / book increased by 613.0% year-over-year, from 0.7× to 4.8×.
What is the long-term trend for Shattuck Labs, Inc.'s price / book?
Over 5 years (2020 to 2025), Shattuck Labs, Inc.'s price / book has grown at a -17.1% compound annual growth rate (CAGR), from 7.1× to 2.8×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.